Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Trestle Holdings was a healthcare technology company that specialized in digital pathology and remote microscopy solutions. The company developed software and hardware platforms, such as the MedMicro and MedWork systems, which allowed pathologists to digitize, view, and share high-resolution images of tissue slides for diagnostic and research purposes. By enabling telepathology and virtual slide management, Trestle aimed to improve the efficiency and accuracy of cancer diagnostics and facilitate collaborative research. The company was publicly traded under the symbol TLHO before being acquired by Clarient in 2005 to enhance their diagnostic services and digital imaging capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Trestle Holdings.